Market Notice 50/21 – Information regarding the split and reclassification of shares in Hamlet Pharma AB
At the extraordinary general meeting in Hamlet Pharma AB on March 2, 2021 it was decided that the company's common shares will undergo a split with relation 3:1 and be reclassified as A- and B-shares. The B-shares will be traded on Spotlight. The A-shares will not be listed. The reclassification means that the B-shares will be traded with a new ISIN code, share name, short name and FISN code. Last day of trading before the split and reclassification is March 12, 2021. The Company’s order book will be flushed due to the split. Last day of trading in the common share: March 12,